Quantification of extracellular volume with cardiac computed tomography in patients with dilated cardiomyopathy

J Cardiovasc Comput Tomogr

27 June Jun 2023 one year ago
  • Baggiano A, Mushtaq S, Annoni A, Formenti A, Fusini L, Maragna R, Penso M, Volpe A, Pepi M, Pontone G.

Cardiac computed tomography (CCT) was recently validated to measure extracellular volume (ECV) in the setting of cardiac amyloidosis, showing good agreement with cardiovascular magnetic resonance (CMR). However, no evidence is available with a whole-heart single source, single energy CT scanner in the clinical context of newly diagnosed left ventricular dysfunction. Therefore, the aim of this study was to test the diagnostic accuracy of ECVCCT in patients with a recent diagnosis of dilated cardiomyopathy, having ECVCMR as the reference technique.

Reference: Quantification of extracellular volume with cardiac computed tomography in patients with dilated cardiomyopathy.
Baggiano A, Conte E, Spiritigliozzi L, Mushtaq S, Annoni A, Carerj ML, Cilia F, Fazzari F, Formenti A, Frappampina A, Fusini L, Gaudenzi Asinelli M, Junod D, Mancini ME, Mantegazza V, Maragna R, Marchetti F, Penso M, Tassetti L, Volpe A, Baessato F, Guglielmo M, Rossi A, Rovera C, Andreini D, Rabbat MG, Guaricci AI, Pepi M, Pontone G. J Cardiovasc Comput Tomogr. 2023 May 3:S1934-5925(23)00118-1.

Go to PubMed